Neuroone Medical TechnologieNMTC
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 24 institutions reported holding Neuroone Medical Technologie (NMTC) in their 13F filings, up 23 from Q1 2026. 6 opened new positions and 0 sold out. The largest holders were Bleichroeder LP ($2.0M), Vanguard Capital Management LLC ($1.1M) and Bard Associates Inc. ($929K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Neuroone Medical Technologie
- CUSIP
- 64130M308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $165K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 179,803 shares bought and 49,681 shares sold, net +130,123 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Bleichroeder LP | 0.36% | No change | 666,666 | $2.0M |
| Vanguard Capital Management LLC | 0.00% | Add +51.5% | 352,774 | $1.1M |
| Bard Associates Inc. | 0.21% | Reduce -0.4% | 305,428 | $929K |
| Perkins Capital Management Inc. | 0.56% | Reduce -0.3% | 244,656 | $744K |
| Geode Capital Management, LLC | 0.00% | Reduce -8.8% | 93,555 | $284K |
| Sio Capital Management, LLC | 0.04% | No change | 82,767 | $252K |
| Renaissance Technologies | 0.00% | Reduce -35.1% | 70,861 | $215K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +0.7% | 49,018 | $149K |
| Essex Investment Management Co. LLC | 0.02% | Reduce -0.2% | 43,578 | $132K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 28,499 | $87K |
| BlackRock, Inc. | 0.00% | New | 25,121 | $76K |
| Northern Trust Corp. | 0.00% | Add +14.5% | 21,398 | $65K |
| Citadel Advisors | 0.00% | New | 15,032 | $46K |
| Susquehanna International Group, LLP | 0.00% | New | 13,520 | $41K |
| Belpointe Asset Management LLC | 0.00% | No change | 12,500 | $38K |
| Legato Capital Management LLC | 0.00% | No change | 10,273 | $31K |
| UBS Group AG | 0.00% | Add +14472.2% | 2,623 | $8K |
| Morgan Stanley | 0.00% | Add +2.1% | 2,058 | $6K |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 361 | $1K |
| Wells Fargo & Company | 0.00% | Reduce -0.4% | 166 | $505 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 112 | $340 |
| Barclays PLC | 0.00% | New | 76 | $231 |
| Osaic Holdings, Inc. | 0.00% | Reduce -0.6% | 58 | $176 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -35.0% | 13 | $40 |
"% of holder's portfolio" is NMTC's weight in each manager's 13F, not the share of Neuroone Medical Technologie the manager owns.